Viveve Medical, Inc. (VIVE)
OTCMKTS: VIVE · Delayed Price · USD
0.0004
0.00 (0.00%)
Jul 19, 2024, 4:00 PM EDT - Market open
Viveve Medical Market Cap
Viveve Medical has a market cap or net worth of $4.29 thousand as of July 22, 2024. Its market cap has decreased by -99.97% in one year.
Market Cap
4.29K
Enterprise Value
-21.71K
1-Year Change
-99.97%
Ranking
n/a
Category
Stock Price
$0.00
Market Cap Chart
Since May 3, 2010, Viveve Medical's market cap has decreased from $4.90M to $4.29K, a decrease of -99.91%. That is a compound annual growth rate of -42.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 18, 2023 | 2.40M | -47.83% |
| Dec 30, 2022 | 4.60M | -61.98% |
| Dec 31, 2021 | 12.10M | 18.63% |
| Dec 31, 2020 | 10.20M | 436.84% |
| Dec 31, 2019 | 1.90M | -94.26% |
| Dec 31, 2018 | 33.10M | -65.70% |
| Dec 29, 2017 | 96.50M | 76.09% |
| Dec 30, 2016 | 54.80M | 26.27% |
| Dec 31, 2015 | 43.40M | 435.80% |
| Dec 31, 2014 | 8.10M | 39.66% |
| Dec 31, 2013 | 5.80M | 38.10% |
| Dec 31, 2012 | 4.20M | 31.25% |
| Dec 30, 2011 | 3.20M | 60.00% |
| Dec 31, 2010 | 2.00M | -59.18% |
View and export this data all the way back to 2010.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly | 814.94B |
| Novo Nordisk | 579.91B |
| UnitedHealth Group | 520.32B |
| Johnson & Johnson | 372.29B |
| Merck & Co. | 318.55B |
| AbbVie | 304.29B |
| AstraZeneca | 244.04B |
| Novartis AG | 207.64B |